Your browser doesn't support javascript.
loading
Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
Slootweg, M C; Ohlsson, C; Salles, J P; de Vries, C P; Netelenbos, J C.
Affiliation
  • Slootweg MC; Research Institute for Endocrinology, Free University Hospital, Amsterdam, The Netherlands.
Endocrinology ; 136(10): 4210-7, 1995 Oct.
Article in En | MEDLINE | ID: mdl-7545101
ABSTRACT
GH exerts its biological actions on osteoblasts through a specific high affinity receptor expressed on these cells. GH receptor binding is positively modulated by a number of factors, including retinoic acid and dexamethasone, whereas fetal calf serum strongly decreases the binding. To identify responsible factors in serum, components of serum, the insulin-like growth factors (IGFs)-I and -II, and IGF binding proteins (IGFBPs)-2 and -3 were tested for a possible negative modulatory role. IGF-I and -II decreased [125I]hGH binding at an optimal concentration of 30 ng/ml for IGF-I and 100 ng/ml IGF-II, reducing the binding to 51% and 55%, respectively, of control values. A stimulation of [125I]hGH binding was observed with IGFBP-2 as well as IGFBP-3, inducing an increase to 148% and 151% of control binding at an optimal concentration of 3000 ng/ml for both peptides. The effects of all peptides were dependent on the incubation time, being significantly increased after 8 h of incubation and reaching the full effect thereafter. The effects were declined at 24 h compared with 16 h for IGFBP-2 and -3 but not for IGF-I and -II. Coincubation of the cells with IGF-I and -II and IGFBP-2 and -3 neutralized the effects of the factors alone. In conclusion, these results show that IGF-I and -II on the one hand and IGFBP-2 and -3 on the other hand exert opposite actions on [125I]hGH binding, IGFBP-2 and -3 exerting probably an IGF-independent effect. Further, IGF-I and -II decreased GH receptor messenger RNA (mRNA) levels, as quantified by a solution hybridization ribonuclease protection assay, from 8.65 +/- 1.78 attomoles (amol)/microgram DNA (control) to 2.4 +/- 0.68 and 2.16 +/- 0.92 amol/microgram DNA, respectively. IGFBP-2 increased GH receptor mRNA levels from 5.26 +/- 1.17 (control) to 13.19 +/- 3.48. Incubation with IGFBP-3 did not result in stimulation of GH receptor mRNA levels (8.59 +/- 2.91 amol/microgram DNA). This shows that the mechanism of regulation of the GH receptor is, except for IGFBP-3, at least in part on the mRNA level. Lastly, IGFBP-2 and IGFBP-3 are mitogenic for UMR-106.01 rat osteosarcoma cells, inducing an increase in cell number to 125% and 142% of control cell counts after 48 h of incubation with 1000 ng/ml IGFBP-2 and -3, whereas IGF-I, IGF-II and Long R3 IGF-I did not stimulate proliferation. IGFBP-2 and -3 potentiate hGH induced mitogenesis at low hGH concentrations of both factors, whereas at higher concentrations no such effect is observed.(ABSTRACT TRUNCATED AT 400 WORDS)
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Somatotropin / Insulin-Like Growth Factor I / Insulin-Like Growth Factor II / Carrier Proteins / Osteosarcoma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Endocrinology Year: 1995 Document type: Article Affiliation country: Países Bajos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Somatotropin / Insulin-Like Growth Factor I / Insulin-Like Growth Factor II / Carrier Proteins / Osteosarcoma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Endocrinology Year: 1995 Document type: Article Affiliation country: Países Bajos